Medical device and MedTech insights, news, tips and more

Phoenix Children’s Is the First-Ever Health System in the U.S to Use Medtronic Stealth Autoguide Cranial Robotic Guidance Platform for Neurosurgery

January 22, 2020

Nationally ranked pediatric leader, Phoenix Children’s Hospital, is the first-ever health system in the U.S. to receive and deploy the newly FDA-cleared Medtronic Stealth Autoguide™ platform. Medtronic, a global leader in medical technology, chose Barrow Neurological Institute (BNI) at Phoenix Children’s as its first partner using this robotic technology. The highly advanced surgical tool is intended for use with the Medtronic StealthStation™ system, and Phoenix Children’s Hospital will use it in surgery for pediatric patients suffering from a range of neurological conditions.

“Phoenix Children’s is proud to invest in the best possible technology for use while we provide outstanding care to children,” said Daniel Ostlie, M.D., surgeon in chief and chair of Surgery at Phoenix Children’s. “We are committed to being at the forefront of surgical innovation and having the most advanced solutions for pediatric patients.”

BNI at Phoenix Children’s surgical staff have undergone comprehensive training with the Medtronic team as they prepared to use the Stealth Autoguide robotic guidance system in patient neurosurgery cases in early January.

“The Stealth Autoguide is a tremendous addition to the neurosurgical team’s tools at Phoenix Children’s,” said P. David Adelson, division chief of Neurosurgery and director of BNI at Phoenix Children’s. “Neurosurgery is such an intricate specialty, and having this technology at our fingertips perfectly aligns with our mission to provide state-of-the-art care to improve the health and quality of life for the children we see here.”

Ranked a top pediatric neuroscience, neurosurgery and neurology program by U.S. News & World Report’s Best Children’s Hospitals, BNI at Phoenix Children’s is eager to combine its deep bench of clinical talent with Medtronic’s cutting-edge innovation.

“With our new technology deployed, we are thrilled to work with Phoenix Children’s and to support their mission of providing exceptional care for pediatric patients,” said Dave Anderson, vice president and general manager, Enabling Technologies, which is part of the Restorative Therapies Group at Medtronic.

Phoenix Children’s Hospital Foundation received funding for the Stealth Autoguide from close community partners who support Phoenix Children’s in providing the best care by advancing pediatric medical solutions.

“We are extremely appreciative of the community’s support of the Stealth Autoguide,” said Steve Schnall, senior vice president at Phoenix Children’s Hospital Foundation. “We are grateful to the Del E. Webb Foundation, Thunderbirds Charities, and WINGS, the women’s auxiliary board of Phoenix Children’s, for investing in this state-of-the-art technology.”

See Full Press Release: Phoenix Children’s Is the First-Ever Health System in the U.S to Use Medtronic Stealth Autoguide™ Cranial Robotic Guidance Platform for Neurosurgery | Medtronic


Written by: Medtronic


Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?

Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.